APLN and prostate cancer: Moreover, incubation with ERK, p38, and JNK inhibitors counteracted the apelin-induced effects on miR-8070 synthesis but not on WT luciferase activity (Fig. 5G-I), suggesting that apelin promotes integrin-dependent prostate cancer motility by suppressing miR-8070 via the MAPK pathway.